This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Asae Shintani: Innovator in Biopharmaceuticals
Introduction
Asae Shintani is a prominent inventor based in Suita, Japan. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that promote the production and secretion of TGF-β superfamily proteins. Her work is crucial for addressing various medical conditions.
Latest Patents
Asae Shintani holds a patent for a TGF-β superfamily production/secretion promoter. This invention includes a compound represented by a specific formula, which features various functional groups. The compound is designed to be useful as an agent for the prophylaxis or treatment of dysautonomia, bladder dysfunction, hearing impairment, and bone disease, among other conditions.
Career Highlights
Shintani is currently associated with Takeda Pharmaceutical Company Limited, where she continues to advance her research and innovations. Her work has been instrumental in developing therapeutic solutions that can significantly improve patient outcomes.
Collaborations
Throughout her career, Asae Shintani has collaborated with notable colleagues, including Yasuo Sugiyama and Masatoshi Hazama. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Asae Shintani's contributions to the field of biopharmaceuticals exemplify the impact of innovative research on healthcare. Her patent for the TGF-β superfamily production/secretion promoter highlights her commitment to advancing medical science and improving patient care.